A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect

被引:80
作者
Lopez-Serra, Paula [1 ]
Marcilla, Miguel [2 ]
Villanueva, Alberto [3 ]
Ramos-Fernandez, Antonio [4 ]
Palau, Anna [1 ]
Leal, Lucia [1 ]
Wahi, Jessica E. [1 ]
Setien-Baranda, Fernando [1 ]
Szczesna, Karolina [1 ]
Moutinho, Catia [1 ]
Martinez-Cardus, Anna [1 ]
Heyn, Holger [1 ]
Sandoval, Juan [1 ]
Puertas, Sara [3 ]
Vidal, August [5 ]
Sanjuan, Xavier [5 ]
Martinez-Balibrea, Eva [6 ]
Vinals, Francesc [3 ,7 ]
Perales, Jose C. [7 ]
Bramsem, Jesper B. [8 ]
Orntoft, Torben F. [8 ]
Andersen, Claus L. [8 ]
Tabernero, Josep [9 ]
McDermott, Ultan [10 ]
Boxer, Matthew B. [11 ]
Vander Heiden, Matthew G. [12 ,13 ]
Pablo Albar, Juan [2 ]
Esteller, Manel [1 ,7 ,14 ]
机构
[1] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain
[2] CSIC, Spanish Natl Biotechnol Ctr CNB, Prote Unit, E-28049 Madrid, Spain
[3] Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol ICO, Translat Res Lab, Barcelona 08908, Catalonia, Spain
[4] Proteobotics SL, Spanish Natl Biotechnol Ctr CNB, Madrid 28049, Spain
[5] Bellvitge Univ Hosp, Dept Pathol, Bellvitge Biomed Res Inst IDIBELL, Barcelona 08908, Catalonia, Spain
[6] Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Catalan Inst Oncol ICO, Med Oncol Serv, Barcelona 08916, Catalonia, Spain
[7] Univ Barcelona, Sch Med, Dept Physiol Sci 2, E-08036 Barcelona, Spain
[8] Aarhus Univ Hosp, Dept Mol Med, DK-8200 Aarhus, Denmark
[9] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona 08035, Catalonia, Spain
[10] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England
[11] NIH, Natl Ctr Adv Translat Sci, Rockville, MD 20891 USA
[12] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[13] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[14] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Catalonia, Spain
来源
NATURE COMMUNICATIONS | 2014年 / 5卷
关键词
PYRUVATE-KINASE M2; UNFOLDED PROTEIN RESPONSE; CELL-METABOLISM; CANCER; METHYLATION; LACTATE; PKM2; IDENTIFICATION; TRANSLOCATION; DISLOCATION;
D O I
10.1038/ncomms4608
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer cells possess aberrant proteomes that can arise by the disruption of genes involved in physiological protein degradation. Here we demonstrate the presence of promoter CpG island hypermethylation-linked inactivation of DERL3 (Derlin-3), a key gene in the endoplasmic reticulum-associated protein degradation pathway, in human tumours. The restoration of in vitro and in vivo DERL3 activity highlights the tumour suppressor features of the gene. Using the stable isotopic labelling of amino acids in cell culture workflow for differential proteome analysis, we identify SLC2A1 (glucose transporter 1, GLUT1) as a downstream target of DERL3. Most importantly, SLC2A1 overexpression mediated by DERL3 epigenetic loss contributes to the Warburg effect in the studied cells and pinpoints a subset of human tumours with greater vulnerability to drugs targeting glycolysis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Glucose transporters in cancer metabolism
    Adekola, Kehinde
    Rosen, Steven T.
    Shanmugam, Mala
    [J]. CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) : 650 - 654
  • [2] Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
    Anastasiou, Dimitrios
    Yu, Yimin
    Israelsen, William J.
    Jiang, Jian-Kang
    Boxer, Matthew B.
    Hong, Bum Soo
    Tempel, Wolfram
    Dimov, Svetoslav
    Shen, Min
    Jha, Abhishek
    Yang, Hua
    Mattaini, Katherine R.
    Metallo, Christian M.
    Fiske, Brian P.
    Courtney, Kevin D.
    Malstrom, Scott
    Khan, Tahsin M.
    Kung, Charles
    Skoumbourdis, Amanda P.
    Veith, Henrike
    Southall, Noel
    Walsh, Martin J.
    Brimacombe, Kyle R.
    Leister, William
    Lunt, Sophia Y.
    Johnson, Zachary R.
    Yen, Katharine E.
    Kunii, Kaiko
    Davidson, Shawn M.
    Christofk, Heather R.
    Austin, Christopher P.
    Inglese, James
    Harris, Marian H.
    Asara, John M.
    Stephanopoulos, Gregory
    Salituro, Francesco G.
    Jin, Shengfang
    Dang, Lenny
    Auld, Douglas S.
    Park, Hee-Won
    Cantley, Lewis C.
    Thomas, Craig J.
    Heiden, Matthew G. Vander
    [J]. NATURE CHEMICAL BIOLOGY, 2012, 8 (10) : 839 - 847
  • [3] Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
    Anastasiou, Dimitrios
    Poulogiannis, George
    Asara, John M.
    Boxer, Matthew B.
    Jiang, Jian-kang
    Shen, Min
    Bellinger, Gary
    Sasaki, Atsuo T.
    Locasale, Jason W.
    Auld, Douglas S.
    Thomas, Craig J.
    Vander Heiden, Matthew G.
    Cantley, Lewis C.
    [J]. SCIENCE, 2011, 334 (6060) : 1278 - 1283
  • [4] A decade of exploring the cancer epigenome - biological and translational implications
    Baylin, Stephen B.
    Jones, Peter A.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (10) : 726 - 734
  • [5] High density DNA methylation array with single CpG site resolution
    Bibikova, Marina
    Barnes, Bret
    Tsan, Chan
    Ho, Vincent
    Klotzle, Brandy
    Le, Jennie M.
    Delano, David
    Zhang, Lu
    Schroth, Gary P.
    Gunderson, Kevin L.
    Fan, Jian-Bing
    Shen, Richard
    [J]. GENOMICS, 2011, 98 (04) : 288 - 295
  • [6] Cancer's sweet tooth
    Bui, Thi
    Thompson, Craig B.
    [J]. CANCER CELL, 2006, 9 (06) : 419 - 420
  • [7] Molecular chaperones and protein quality control
    Bukau, Bernd
    Weissman, Jonathan
    Horwich, Arthur
    [J]. CELL, 2006, 125 (03) : 443 - 451
  • [8] Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
    Chan, Denise A.
    Sutphin, Patrick D.
    Nguyen, Phuong
    Turcotte, Sandra
    Lai, Edwin W.
    Banh, Alice
    Reynolds, Gloria E.
    Chi, Jen-Tsan
    Wu, Jason
    Solow-Cordero, David E.
    Bonnet, Muriel
    Flanagan, Jack U.
    Bouley, Donna M.
    Graves, Edward E.
    Denny, William A.
    Hay, Michael P.
    Giaccia, Amato J.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (94)
  • [9] Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
    Chen, J.
    Xie, J.
    Jiang, Z.
    Wang, B.
    Wang, Y.
    Hu, X.
    [J]. ONCOGENE, 2011, 30 (42) : 4297 - 4306
  • [10] Therapeutic targets in cancer cell metabolism and autophagy
    Cheong, Heesun
    Lu, Chao
    Lindsten, Tullia
    Thompson, Craig B.
    [J]. NATURE BIOTECHNOLOGY, 2012, 30 (07) : 671 - 678